S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
HIMS · Hims & Hers Health, Inc.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
Hims & Hers Health Inc (HIMS)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$29.20
-0.03
(-0.10%)
● At close: October 21 at 4:00:00 PM EDT
$28.90
-0.31
(-1.06%)
Overnight:
12:09:59 AM EDT
DAY'S RANGE
$29.20
$28.88
$29.90
52-WEEK RANGE
$29.20
$13.74
$52.41
What's happening
- HIMS is down 0.10% today, trading at $29.20. — Live quote
- Volume today (210,072) is well below its 3-month average of 13,177,190. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.37 actual vs. $-0.01 estimated (-2487.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 7
Hold 13
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (22 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
HIMS
-10.04%
vs S&P 500
-22.82%
1-YEAR RETURN
HIMS
-43.13%
vs S&P 500
-57.69%
6-MONTH RETURN
HIMS
+8.23%
3-MONTH RETURN
HIMS
-10.75%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.37
Est. $-0.01
MISS -2487.4%
2026-04-26 (Q1 2026)
$-0.19
Est. $0.04
MISS -529.9%
2026-01-26 (Q4 2025)
$0.08
Est. $0.05
BEAT +71.3%
2025-10-26 (Q3 2025)
$0.06
Est. $0.11
MISS -43.6%
Valuation Measures & Ratios
Enterprise Value4$7.57B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)2.64
Price / Book724.76
EV4 / Revenue2.94
EV4 / EBITDA201.50
Profit Margin-5.51%
Operating Margin-5.99%
Return on Equity (ROE8)-30.03%
Return on Assets (ROA9)-5.52%
Avg Volume (3M)13,177,190
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $8.09B | $4.79B | $14.91B | $12.47B | $7.31B |
| P/E | -67.31 | 305.94 | 81.31 | 68.96 | 48.92 |
| Price/Sales | 3.23 | 2.05 | 6.99 | 6.75 | 4.62 |
| Price/Book | 24.95 | 10.73 | 25.66 | 22.17 | 13.32 |
| EV/Revenue | 2.98 | 1.95 | 6.83 | 6.14 | 4.45 |
| EV/EBITDA | -130.19 | 59.70 | 91.24 | — | — |
| ROE | -37.07% | 3.51% | 31.56% | 32.14% | 27.22% |
| ROA | -3.31% | 0.69% | 8.21% | 9.63% | 16.77% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short54,769,436
Change from Prior Settlement+3.49%
% of Float—
Days to Cover (Short Ratio)5.26
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 38.2% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-15; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -5.5%. Finnhub fundamentals ↗
- Trailing 52-week price return is -43.1%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on HIMS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $753.2M | $608.1M | $599.0M | $544.8M | $586.0M | $401.6M | $315.6M | $278.2M |
| Gross profit | $480.8M | $396.8M | $442.1M | $416.2M | $430.7M | $317.9M | $256.6M | $229.1M |
| Operating income | -$97.2M | -$78.3M | $11.8M | $26.7M | $57.9M | $22.4M | $11.0M | $9.9M |
| Net income | -$86.3M | -$92.1M | $15.8M | $42.5M | $49.5M | $75.6M | $13.3M | $11.1M |
| EPS (diluted) | $-0.37 | $-0.40 | $0.06 | $0.17 | $0.20 | $0.32 | $0.06 | $0.05 |
| EPS (basic) | $-0.37 | $-0.40 | $0.07 | $0.19 | $0.22 | $0.35 | $0.06 | $0.05 |
| Operating margin | -$13 | -$13 | $2 | $5 | $10 | $6 | $3 | $4 |
| Net margin | -$11 | -$15 | $3 | $8 | $8 | $19 | $4 | $4 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | $891.7M | $707.5M | $602.3M |
| Total liabilities | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | $342.4M | $230.8M | $162.2M |
| Stockholders' equity | $324.1M | $446.2M | $540.9M | $581.0M | $562.7M | $549.3M | $476.7M | $440.1M |
| Total current assets | $1.38B | $1.05B | $767.6M | $845.3M | $1.36B | $447.0M | $395.8M | $326.4M |
| Total current liabilities | $1.48B | $618.8M | $404.4M | $450.8M | $272.2M | $280.4M | $221.4M | $152.6M |
| Cash & equivalents | $609.8M | $222.3M | $228.6M | $345.8M | $1.12B | $273.7M | $220.6M | $165.5M |
| Accounts receivable | $375.3M | $149.6M | $32.1M | — | — | — | — | — |
| Inventory | $87.8M | $79.1M | $80.1M | $106.0M | $141.8M | $76.1M | $64.4M | $49.1M |
| Other current assets | $11.7M | $10.6M | $4.4M | $34.6M | $20.6M | $12.2M | $400.0K | $5.7M |
| Marketable securities (non-current) | — | — | — | $438.3M | — | — | $0 | — |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Goodwill | $1.10B | $342.8M | $278.3M | $259.2M | $117.8M | $117.8M | $112.7M | $112.7M |
| Intangible assets | $422.8M | $261.0M | $196.1M | $194.9M | $40.7M | $43.4M | $43.4M | $44.8M |
| Other non-current assets | $78.3M | $47.6M | $29.7M | $3.9M | $1.9M | $1.9M | $147.0K | $138.0K |
| Accounts payable | $501.3M | $306.9M | $143.3M | $198.4M | $105.0M | $108.9M | $91.2M | $75.4M |
| Accrued liabilities | $210.3M | $90.7M | $77.0M | $80.1M | $65.7M | $56.9M | $53.0M | $43.2M |
| Deferred revenue (current) | $141.4M | $165.1M | $127.2M | $118.5M | $98.4M | $110.8M | $75.3M | $32.2M |
| Other non-current liabilities | $8.7M | $12.9M | $6.2M | $6.1M | $1.4M | $2.4M | $0 | $0 |
| Common stock & paid-in capital | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K |
| Retained earnings | -$292.2M | -$205.9M | -$113.8M | -$134.4M | -$150.1M | -$192.7M | -$242.1M | -$268.2M |
| Accumulated other comprehensive income (loss) | -$46.0M | -$4.4M | $2.3M | $921.0K | $822.0K | -$164.0K | -$324.0K | $229.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$35.9M | $89.4M | $61.3M | $148.7M | -$19.1M | $109.1M | $86.4M | $85.3M |
| Investing cash flow | $84.5M | -$15.4M | -$83.7M | -$887.4M | -$21.1M | -$32.8M | -$17.2M | -$10.4M |
| Financing cash flow | $341.8M | -$77.9M | -$97.5M | -$39.0M | $889.2M | -$23.0M | -$13.7M | -$38.8M |
| Depreciation & amortization | $29.5M | $22.0M | $18.1M | $17.7M | $10.5M | $8.3M | $6.1M | $4.4M |
| Share-based compensation | $42.1M | $36.9M | $34.5M | $40.2M | $35.7M | $24.9M | $24.3M | $24.9M |
| Deferred income taxes | -$9.4M | -$14.0M | -$3.5M | $862.0K | -$9.5M | -$890.0K | -$7.3M | -$54.3M |
| Change in inventory | -$6.0M | $20.3M | -$26.4M | -$37.3M | $65.7M | $11.7M | $15.3M | $8.2M |
| Change in accounts payable | $156.2M | $167.6M | -$45.8M | $71.0M | -$9.3M | $14.5M | $8.7M | $18.9M |
| Purchases of investments | — | — | $12.3M | $713.6M | $0 | $0 | $10.0M | $53.1M |
| Sales/maturities of investments | $274.1M | $76.7M | $0 | $0 | $0 | $0 | $0 | $725.0K |
| Share repurchases | — | — | $80.5M | $9.5M | $0 | $0 | $5.0M | $30.0M |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $23.1M | $39.2M | $21.7M | $32.5M | $36.8M | $25.7M | $19.4M | $10.8M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.0M | $526.9M | $271.9M |
| Gross profit | $1.73B | $1.17B | $714.9M | $408.7M | $204.5M |
| Operating income | $105.6M | $61.9M | -$29.5M | -$68.7M | -$115.0M |
| Net income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M |
| EPS (diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
| EPS (basic) | $0.57 | $0.58 | $-0.11 | $-0.32 | $-0.58 |
| Operating margin | $4 | $4 | -$3 | -$13 | -$42 |
| Net margin | $5 | $9 | -$3 | -$12 | -$40 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.15B | $707.5M | $441.2M | $366.3M | $420.6M |
| Total liabilities | $1.61B | $230.8M | $97.2M | $54.6M | $86.0M |
| Stockholders' equity | $540.9M | $476.7M | $344.0M | $311.7M | $334.6M |
| Total current assets | $767.6M | $395.8M | $265.1M | $216.6M | $269.9M |
| Total current liabilities | $404.4M | $221.4M | $88.5M | $47.9M | $79.2M |
| Cash & equivalents | $228.6M | $220.6M | $96.7M | $46.8M | $71.8M |
| Inventory | $80.1M | $64.4M | $22.5M | $21.6M | $13.6M |
| Other current assets | $4.4M | $400.0K | $4.2M | $1.8M | $890.0K |
| Property, plant & equipment | — | — | — | $3.0M | $2.2M |
| Goodwill | $278.3M | $112.7M | $110.9M | $110.9M | $110.9M |
| Intangible assets | $196.1M | $43.4M | $18.6M | $21.8M | $25.9M |
| Other non-current assets | $29.7M | $147.0K | $91.0K | $33.0K | $7.9M |
| Accounts payable | $143.3M | $91.2M | $43.1M | $32.4M | $19.6M |
| Accrued liabilities | $78.5M | $53.0M | $29.0M | $12.4M | $12.2M |
| Deferred revenue (current) | $127.2M | $75.3M | $7.7M | $1.5M | $3.2M |
| Other non-current liabilities | $11.7M | $0 | $22.0K | $35.0K | $629.0K |
| Common stock & paid-in capital | $23.0K | $22.0K | $21.0K | $21.0K | $20.0K |
| Retained earnings | -$113.8M | -$242.1M | -$368.2M | -$344.6M | -$279.0M |
| Accumulated other comprehensive income (loss) | $2.3M | -$324.0K | -$124.0K | -$277.0K | -$137.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M |
| Investing cash flow | -$1.02B | -$19.0M | -$12.1M | $34.7M | -$156.3M |
| Financing cash flow | $729.6M | -$107.8M | -$11.5M | -$33.1M | $235.0M |
| Depreciation & amortization | $54.5M | $17.1M | $9.5M | $7.5M | $4.1M |
| Share-based compensation | $135.2M | $92.3M | $66.1M | $42.8M | $67.2M |
| Deferred income taxes | -$13.0M | -$61.6M | -$13.0K | -$594.0K | -$3.4M |
| Change in inventory | $13.7M | $41.6M | $902.0K | $8.0M | $9.6M |
| Change in accounts payable | $30.3M | $43.7M | $7.3M | $12.7M | $9.9M |
| Purchases of investments | $725.8M | $160.6M | $157.2M | $187.7M | $266.6M |
| Sales/maturities of investments | $0 | $725.0K | $1.6M | $35.8M | $3.5M |
| Share repurchases | $90.0M | $83.0M | $2.0M | $0 | $0 |
| Debt issued | — | — | — | — | $0 |
| Debt repaid | — | — | — | $0 | $0 |
| Tax withholding on stock comp | $116.7M | $52.5M | $14.1M | $3.9M | $6.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding HIMS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers52.0%
Shares Outstanding233,297,933
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,703,514 | $995.2M | 12.30% | +9.0% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10,559,314 | $366.1M | 4.53% | +3.7% | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,541,384 | $330.8M | 4.09% | +2.2% | 2026-06-30 |
| State Street Corp | 8,145,699 | $282.4M | 3.49% | +9.2% | 2026-08-07 |
| Morgan Stanley | 7,152,498 | $248.0M | 3.07% | -19.5% | 2026-08-11 |
| Divisadero Street Capital Management, LP | 6,009,505 | $208.3M | 2.58% | +1179.1% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 5,681,832 | $197.0M | 2.44% | +9.3% | 2026-08-12 |
| Goldman Sachs Group Inc | 5,173,865 | $179.4M | 2.22% | +110.8% | 2026-08-14 |
| Jpmorgan Chase & Co | 4,766,781 | $159.5M | 2.04% | -9.0% | 2026-08-12 |
| FMR LLC | 4,323,292 | $149.9M | 1.85% | +4535.2% | 2026-08-13 |
| MARSHALL WACE, LLP | 4,217,767 | $146.2M | 1.81% | +482.4% | 2026-08-13 |
| UBS Group AG | 2,660,810 | $92.3M | 1.14% | -35.9% | 2026-08-13 |
| Northern Trust Corp | 2,594,277 | $89.9M | 1.11% | +6.5% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,453,787 | $85.1M | 1.05% | +4.0% | 2026-08-14 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 2,346,282 | $81.3M | 1.01% | +0.3% | 2026-07-30 |
| Bank Of America Corp /De/ | 2,312,272 | $80.2M | 0.99% | -46.9% | 2026-08-14 |
| Principal Financial Group Inc | 1,667,073 | $57.8M | 0.71% | +30.0% | 2026-07-29 |
| VANGUARD FIDUCIARY TRUST CO | 1,522,249 | $52.8M | 0.65% | +5.0% | 2026-06-30 |
| Bank of New York Mellon Corp | 1,333,146 | $46.2M | 0.57% | -0.5% | 2026-08-06 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1,129,781 | $37.7M | 0.48% | +54.2% | 2026-08-10 |
| Franklin Templeton Inc | 1,032,639 | $35.8M | 0.44% | +739.8% | 2026-08-04 |
| JANE STREET GROUP, LLC | 1,000,484 | $34.7M | 0.43% | +316.6% | 2026-08-14 |
| Clear Street Group Inc. | 989,913 | $34.3M | 0.42% | -24.4% | 2026-08-04 |
| Marex Group Ltd | 973,771 | $33.8M | 0.42% | -27.3% | 2026-08-14 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 932,220 | $32.3K | 0.40% | -34.2% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-06-18 to 2026-10-14
Recent transactions
- Insiders have net sold 193,780 shares over the last 182 days, across 0 purchases and 14 sales.
- Most recent: Boughton Soleil (Chief Legal Officer) — Open market sale of 3,461 shares on 2026-10-14.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)193,780 sh(14 txns)
Net Shares-193,780
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Boughton Soleil | Chief Legal Officer | Open market sale | 2026-10-14 | 3,461 |
| Okupe Oluyemi | Chief Financial Officer | Open market sale | 2026-10-01 | 2,000 |
| Chi Michael | Chief Operating Officer | Open market sale | 2026-09-15 | 14,027 |
| Elshenawy Mohamed | CTO | Open market sale | 2026-09-15 | 7,954 |
| Dudum Andrew | Chief Executive Officer | Other acquisition/disposition | 2026-08-27 | 977,566 |
| Autor Deborah M. | Chief Policy Officer | Open market sale | 2026-08-18 | 16,773 |
| Schultz Kare | Director | Option exercise | 2026-08-14 | 6,623 |
| Carroll Patrick Harrison | Chief Medical Officer | Option exercise | 2026-08-14 | 260 |
| WELLS DAVID B | Director | Option exercise | 2026-08-14 | 778 |
| Becklund Irene | PAO | Option exercise | 2026-08-14 | 13,685 |
| Payne Christopher D | Director | Option exercise | 2026-08-14 | 545 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-14 | Boughton Soleil | Chief Legal Officer | Open market sale | 3,461 | $29.06 |
| 2026-10-01 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 2,000 | $29.70 |
| 2026-09-30 | Boughton Soleil | Chief Legal Officer | Open market sale | 3,461 | $29.17 |
| 2026-09-22 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 14,000 | $5.01 |
| 2026-09-22 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 29,277 | $29.95 |
| 2026-09-17 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 12,313 | $28.82 |
| 2026-09-16 | Boughton Soleil | Chief Legal Officer | Open market sale | 6,236 | $27.86 |
| 2026-09-15 | Chi Michael | Chief Operating Officer | Open market sale | 14,027 | $28.39 |
| 2026-09-15 | Elshenawy Mohamed | CTO | Open market sale | 7,954 | $28.39 |
| 2026-09-02 | Boughton Soleil | Chief Legal Officer | Open market sale | 3,458 | $28.33 |
| 2026-08-27 | Dudum Andrew | Chief Executive Officer | Other acquisition/disposition | 977,566 | $0.00 |
| 2026-08-25 | Dudum Andrew | Chief Executive Officer | Gift | 463,289 | $0.00 |
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 4,938 | $5.01 |
| 2026-08-19 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 4,938 | $29.99 |
| 2026-08-19 | Boughton Soleil | Chief Legal Officer | Open market sale | 25,111 | $27.55 |
| 2026-08-18 | Autor Deborah M. | Chief Policy Officer | Open market sale | 16,773 | $27.85 |
| 2026-08-17 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 9,388 | $5.01 |
| 2026-08-17 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 9,388 | $27.89 |
| 2026-08-14 | Boughton Soleil | Chief Legal Officer | Option exercise | 42,261 | — |
| 2026-08-14 | Boughton Soleil | Chief Legal Officer | Tax withholding | 21,500 | $28.15 |
| 2026-08-14 | Schultz Kare | Director | Option exercise | 6,623 | — |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Option exercise | 260 | — |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Option exercise | 25,927 | — |
| 2026-08-14 | Carroll Patrick Harrison | Chief Medical Officer | Tax withholding | 10,201 | $28.15 |
| 2026-08-14 | Dudum Andrew | Chief Executive Officer | Option exercise | 154,993 | — |
| 2026-08-14 | Dudum Andrew | Chief Executive Officer | Tax withholding | 78,859 | $28.15 |
| 2026-08-14 | Chi Michael | Chief Operating Officer | Option exercise | 86,265 | — |
| 2026-08-14 | Chi Michael | Chief Operating Officer | Tax withholding | 47,702 | $28.15 |
| 2026-08-14 | Okupe Oluyemi | Chief Financial Officer | Option exercise | 71,616 | — |
| 2026-08-14 | Okupe Oluyemi | Chief Financial Officer | Tax withholding | 36,437 | $28.15 |
| 2026-08-14 | Autor Deborah M. | Chief Policy Officer | Option exercise | 32,920 | — |
| 2026-08-14 | Autor Deborah M. | Chief Policy Officer | Tax withholding | 16,147 | $28.15 |
| 2026-08-14 | WELLS DAVID B | Director | Option exercise | 778 | — |
| 2026-08-14 | Elshenawy Mohamed | CTO | Option exercise | 188,285 | — |
| 2026-08-14 | Elshenawy Mohamed | CTO | Tax withholding | 95,798 | $28.15 |
| 2026-08-14 | Becklund Irene | PAO | Option exercise | 13,685 | — |
| 2026-08-14 | Becklund Irene | PAO | Tax withholding | 6,490 | $28.15 |
| 2026-08-14 | Payne Christopher D | Director | Option exercise | 545 | — |
| 2026-06-18 | Okupe Oluyemi | Chief Financial Officer | Open market sale | 55,383 | $35.09 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:20 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-15 | 4 | 2026-10-14 | View on SEC.gov → |
| 2026-10-07 | 8-K | 2026-10-07 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-23 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-17 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-02 | View on SEC.gov → |
| 2026-08-27 | 4 | 2026-08-25 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
Recent news
Headlines about HIMS (Hims & Hers Health, Inc.). Links open the publisher — we don’t host full articles.
-
What Does Progyny's Falling Multiple Really Say?
Yahoo · 2026-10-22 -
Hims & Hers Health, Inc. (HIMS) Stock Forecasts
Yahoo Finance · 2026-10-21 -
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Hims & Hers Out with New TRT, Shares Break Even
Baystreet.ca · 2026-10-21 -
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
Yahoo · 2026-10-21 -
Hims & Hers Health Inc. Stock Grades | HIMS
Barron's · 2026-10-21 -
Hims & Hers Health stock outlook: Upside likely as momentum improves and buyers dominate
Traders Union · 2026-10-21 -
Hims & Hers Health, Inc. Securities Fraud Class Action
GlobeNewswire · 2026-10-21
No headlines in this category right now — try “All”.